May 3, 2005-LifeTree eClinical, a member of the FFF Enterprises Inc. family of companies and a leading provider of clinical electronic data capture and analysis systems, today announced the launch of LifeTreeHub 1.0, an advanced platform for aggregating clinical trial documents, web-based messaging and virtual meeting capabilities.
TEMECULA, Calif., May 3, 2005-LifeTree eClinical, a member of the FFF Enterprises Inc. family of companies and a leading provider of clinical electronic data capture and analysis systems, today announced the launch of LifeTreeHub(tm) 1.0, an advanced platform for aggregating clinical trial documents, web-based messaging and virtual meeting capabilities.
A stand-alone, customizable portal, LifeTreeHub provides a secure electronic repository for the storage and retrieval of medical documents and clinical information, including regulatory documents, protocols, investigator CVs and medical licenses. The ability to version and digitally sign documents enhances the system's security. LifeTree ICTM(tm), an electronic data capture and analysis platform, is integrated with LifeTreeHub for a seamless transition from clinical functions to document sharing and retrieval. Used together, LifeTree ICTM and LifeTreeHub provide sponsors and clinical research organizations a comprehensive eClinical solution for their studies.
"I'm very pleased with our steady innovation," said Patrick M. Schmidt, CEO of LifeTree and FFF. "It reflects LifeTree's dedication to continually develop our suite of services and their delivery to our clients."
With LifeTreeHub, LifeTree's clients are easily able to aggregate the vast amount of complex information supporting clinical studies. According to Gary Gabriel, PhD, LifeTree's vice president of sales and business development, "LifeTreeHub is a major advancement for study sponsors and clinical research organizations that must achieve greater efficiency in their clinical trial projects. LifeTree's study portal serves as a hub for storing information about a trial and making it readily available to study sites and sponsors via the Internet. This helps streamline the study initiation, conduct and amendment processes. And the ability to connect clinical trial staff members through our virtual meeting capabilities adds to our mission of improving how individuals work and communicate within the clinical trial process."
About LifeTree eClinical
LifeTree eClinical, also known as LifeTree Technology LLC, is a member of the FFF Enterprises Inc. family of companies, headquartered in Temecula, California. The LifeTree suite of clinical technologies and services has been used in Phase I through IV trials, patient registries and diagnostic and epidemiological studies. LifeTree ICTM, the core technology of the LifeTree eClinical suite, provides tools for clinical study design, data entry and data reporting. The suite is completely workflow driven and contains extensive clinical trial metrics and trial management tools that are built-in for designated roles within the clinical trial process. SAS data on demand and a complete menu for building data reports fully empower a study's data analyst. LifeTree ICTM's newest features include comprehensive patient-safety reporting, medical coding and imaging data capabilities. The clinical data is fully audit trailed, and it is CDISC- and 21 CFR Part 11-compliant. For more information, call 800-211-2799 ext 1356, email info@lifetree-tech.com or visit www.lifetreeclinical.com.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.